SlidesetHIVINTEREST 2020Rapid Antiretroviral Therapy Initiation and the Risk of Mortality and Loss to Follow-Up in Children with HIV - Peter James ElyanuView Slideset
SlidesetHIVINTEREST 2020Monitoring and Management of Treatment Failure Among People on Antiretroviral Therapy in Mozambique: Lessons Learned to Improve Treatment Effectiveness - Laura Marcela TorresView Slideset
SlidesetHIVINTEREST 2020Is the Use of Creatinine Clearance Test at Baseline for PrEP Enrolment Necessary in Resource-Constrained Settings? - David ChilongoziView Slideset
SlidesetHIVINTEREST 2020Case Series of Urethrocutaneous Fistulas After Voluntary Medical Male Circumcision for HIV Prevention—15 African Countries, 2015– 2019 - Todd LucasView Slideset
SlidesetHIVINTEREST 2020Gaining Traction: Promising Shifts in Gender Norms and Intimate Partner Violence During an HIV prevention Trial in South Africa - Ann GottertView Slideset
SlidesetHIVINTEREST 2020A Gap Analysis and Total Quality Leadership and Accountability Intervention Triples HIV Testing Yield among Key Population in Zambia - Florence Tembo MulengaView Slideset
SlidesetHIVINTEREST 2020Traditional Healers Can Increase Uptake of HIV Testing among Adults of Unknown Serostatus: Results from a Cluster Randomized Pilot Study in Southwestern Uganda - Radhika SundararajanView Slideset
SlidesetHIVINTEREST 2020Perceptions, Preferences and Access to Community-Based HIV Testing Services among Men who have Sex with Men (MSM) in Côte d’Ivoire - Maxime InghelsView Slideset
SlidesetHIVINTEREST 2020Index-Linked HIV Testing for Children and Adolescents in Health Facility and Community-Based Settings in Zimbabwe: Findings from the B-GAP Study - Chido Dziva ChikwariView Slideset
SlidesetHIVINTEREST 2020Striving Towards HIV Epidemic Control through Reaching a Population in Correctional Facilities in Namibia - Hilaria AshivudhiView Slideset
SlidesetHIVINTEREST 2020What Shapes Resilience Among People Living with HIV? A Multi-Country Analysis of... - Stella KentusiView Slideset
SlidesetHIVINTEREST 2020Cost-Utility Analysis of Dolutegravir-Versus Efavirenz 400mg- Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon: 96-week Results from the NAMSAL ANRS 12313 Trial - Marwan al Qays BousmahView Slideset
